These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37740740)

  • 21. Unravelling inclusion body myositis using a patient-derived fibroblast model.
    Cantó-Santos J; Valls-Roca L; Tobías E; García-García FJ; Guitart-Mampel M; Esteve-Codina A; Martín-Mur B; Casado M; Artuch R; Solsona-Vilarrasa E; Fernandez-Checa JC; García-Ruiz C; Rentero C; Enrich C; Moreno-Lozano PJ; Milisenda JC; Cardellach F; Grau-Junyent JM; Garrabou G
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):964-977. PubMed ID: 36860172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inclusion body myositis: a case of bilateral extremity weakness.
    Lam L; Scheper S; Zagorski N; Chung M; Noguchi H; Liow KK
    Hawaii J Med Public Health; 2013 Dec; 72(12):417-20. PubMed ID: 24377075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of dysphagic inclusion body myositis.
    Taira K; Mori-Yoshimura M; Yamamoto T; Oya Y; Nishino I; Takahashi Y
    Neuromuscul Disord; 2023 Feb; 33(2):133-138. PubMed ID: 36575104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms.
    Banerji CRS; Cammish P; Evangelista T; Zammit PS; Straub V; Marini-Bettolo C
    Neuromuscul Disord; 2020 Apr; 30(4):315-328. PubMed ID: 32327287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two emerging phenotypes of atypical inclusion body myositis: illustrative cases.
    Salam S; Morrow JM; Howard R; Miller JAL; Quinlivan RM; Machado PM
    Clin Exp Rheumatol; 2023 Mar; 41(2):340-347. PubMed ID: 36861744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophy.
    Dahlqvist JR; Andersen G; Khawajazada T; Vissing C; Thomsen C; Vissing J
    J Neurol; 2019 May; 266(5):1127-1135. PubMed ID: 30778707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inclusion Body Myositis.
    Goyal NA
    Continuum (Minneap Minn); 2022 Dec; 28(6):1663-1677. PubMed ID: 36537974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
    Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
    Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sporadic Inclusion Body Myositis: A Clinicopathological Study.
    Challa S; Jakati S; Narla S; Uppin MS; Kannan MA; Jagarlapudi MKM
    Neurol India; 2021; 69(3):638-641. PubMed ID: 34169859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle Sonography in Inclusion Body Myositis: A Systematic Review and Meta-Analysis of 944 Measurements.
    Abdelnaby R; Mohamed KA; Elgenidy A; Sonbol YT; Bedewy MM; Aboutaleb AM; Ebrahim MA; Maallem I; Dardeer KT; Heikal HA; Gawish HM; Zschüntzsch J
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Facio-scapula-humeral muscular dystrophy: clinical picture and molecular genetics].
    Dorobek M
    Neurol Neurochir Pol; 2003; 37(1):151-9. PubMed ID: 12910837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obstruction-related dysphagia in inclusion body myositis: Cricopharyngeal bar on videofluoroscopy indicates risk of aspiration.
    Taira K; Yamamoto T; Mori-Yoshimura M; Fujita S; Oya Y; Nishino I; Takahashi Y
    J Neurol Sci; 2020 Jun; 413():116764. PubMed ID: 32172012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
    Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
    Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring hand and upper limb function in patients with inclusion body myositis (IBM).
    Hunn S; Alfano L; Seiffert M; Weihl CC
    Neuromuscul Disord; 2023 Aug; 33(8):643-650. PubMed ID: 37451936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A patient with dermatomyositis and systemic sclerosis with preferential facioscapulohumeral muscle involvement and fatal cardiomyopathy].
    Oya Y; Toyama J; Ogawa M; Nonaka I; Kawai M
    Rinsho Shinkeigaku; 2001 Jun; 41(6):289-95. PubMed ID: 11771157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysphagia in facioscapulohumeral muscular dystrophy.
    Wohlgemuth M; de Swart BJ; Kalf JG; Joosten FB; Van der Vliet AM; Padberg GW
    Neurology; 2006 Jun; 66(12):1926-8. PubMed ID: 16801662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle fiber dysfunction contributes to weakness in inclusion body myositis.
    Lassche S; Rietveld A; Heerschap A; van Hees HW; Hopman MT; Voermans NC; Saris CG; van Engelen BG; Ottenheijm CA
    Neuromuscul Disord; 2019 Jun; 29(6):468-476. PubMed ID: 31101463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy.
    Felice KJ; North WA; Moore SA; Mathews KD
    Neurology; 2000 May; 54(10):1927-31. PubMed ID: 10822431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions for dysphagia in long-term, progressive muscle disease.
    Jones K; Pitceathly RD; Rose MR; McGowan S; Hill M; Badrising UA; Hughes T
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD004303. PubMed ID: 26859621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotype may predict the clinical course of facioscapolohumeral muscular dystrophy.
    Ricci G; Cammish P; Siciliano G; Tupler R; Lochmuller H; Evangelista T
    Muscle Nerve; 2019 Jun; 59(6):711-713. PubMed ID: 30895627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.